Keybank National Association OH Grows Position in CIGNA Co. (CI)

Keybank National Association OH boosted its holdings in CIGNA Co. (NYSE:CI) by 0.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 156,151 shares of the health services provider’s stock after purchasing an additional 1,297 shares during the quarter. Keybank National Association OH’s holdings in CIGNA were worth $31,713,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CI. Janus Henderson Group PLC increased its stake in CIGNA by 245.9% in the 2nd quarter. Janus Henderson Group PLC now owns 110,828 shares of the health services provider’s stock valued at $18,549,000 after buying an additional 78,789 shares during the period. Lord Abbett & CO. LLC increased its stake in CIGNA by 2.8% in the 2nd quarter. Lord Abbett & CO. LLC now owns 43,600 shares of the health services provider’s stock valued at $7,298,000 after buying an additional 1,200 shares during the period. Achmea Investment Management B.V. increased its stake in CIGNA by 73.7% in the 2nd quarter. Achmea Investment Management B.V. now owns 18,365 shares of the health services provider’s stock valued at $3,073,000 after buying an additional 7,791 shares during the period. Ardsley Advisory Partners acquired a new position in CIGNA in the 2nd quarter valued at $418,000. Finally, Eqis Capital Management Inc. increased its stake in CIGNA by 3.1% in the 3rd quarter. Eqis Capital Management Inc. now owns 8,949 shares of the health services provider’s stock valued at $1,673,000 after buying an additional 267 shares during the period. 88.60% of the stock is currently owned by institutional investors.

CI has been the topic of several recent research reports. Zacks Investment Research raised shares of CIGNA from a “hold” rating to a “buy” rating and set a $231.00 price objective on the stock in a research note on Friday, December 22nd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $220.00 price target (up from $185.00) on shares of CIGNA in a research note on Friday, November 3rd. Jefferies Group upped their price target on shares of CIGNA from $221.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Goldman Sachs Group initiated coverage on shares of CIGNA in a research note on Wednesday, January 3rd. They set a “neutral” rating and a $247.00 price target on the stock. Finally, Credit Suisse Group initiated coverage on shares of CIGNA in a research note on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price target on the stock. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $210.12.

Shares of CIGNA Co. (NYSE:CI) opened at $195.55 on Thursday. CIGNA Co. has a 1 year low of $141.93 and a 1 year high of $227.13. The company has a quick ratio of 0.39, a current ratio of 0.37 and a debt-to-equity ratio of 0.38. The company has a market cap of $47,680.91, a PE ratio of 22.40, a P/E/G ratio of 1.17 and a beta of 0.45.

CIGNA (NYSE:CI) last released its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, topping the consensus estimate of $1.87 by $0.07. CIGNA had a net margin of 5.38% and a return on equity of 18.84%. The business had revenue of $10.53 billion for the quarter, compared to analyst estimates of $10.28 billion. During the same period in the previous year, the firm earned $1.87 EPS. The business’s revenue for the quarter was up 5.9% compared to the same quarter last year. analysts anticipate that CIGNA Co. will post 12.9 earnings per share for the current fiscal year.

In other CIGNA news, insider Christopher J. Hocevar sold 8,387 shares of the company’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $200.32, for a total value of $1,680,083.84. Following the transaction, the insider now directly owns 12,363 shares in the company, valued at approximately $2,476,556.16. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP John M. Murabito sold 28,037 shares of the company’s stock in a transaction dated Wednesday, January 10th. The shares were sold at an average price of $205.68, for a total transaction of $5,766,650.16. Following the completion of the transaction, the executive vice president now owns 60,290 shares in the company, valued at $12,400,447.20. The disclosure for this sale can be found here. Insiders sold a total of 64,663 shares of company stock worth $13,329,903 over the last quarter. Insiders own 1.30% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Keybank National Association OH Grows Position in CIGNA Co. (CI)” was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.themarketsdaily.com/2018/02/15/keybank-national-association-oh-grows-position-in-cigna-co-ci.html.

CIGNA Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply